Additionally, it has been found that limiting neutrophils infiltration into the pancreatic tumor and lung cancer by CXCR2 inhibitor can promote tumor infiltration of CD8+ T cells and enhance their anti-tumor abilities 50, 51. This evidence concerns the gene CXCR2 and neoplasm.